Brenda Gonzalez

Brenda Gonzalez has a diverse work experience spanning various roles in scientific research and academia. Brenda currently works at Lockwood as a Scientific Director, a position they have held since July 2023. Prior to this, they served as a Senior Associate Scientific Director at Lockwood from January 2022 to September 2023, and as an Associate Scientific Director from January 2021 to January 2022.

Before joining Lockwood, Brenda worked as a Medical Associate at The Scienomics Group from September 2019 to January 2021. Brenda also has a strong academic background, having obtained a PhD from Albert Einstein College of Medicine. Their research focused on the genetics of human aging, specifically examining the role of mitochondrial-pathway proteins in age-related diseases and longevity. Brenda's PhD work took place from August 2013 to September 2019.

Their earlier experiences include working as an Undergraduate Student Researcher at Queens College from January 2010 to May 2013. Here, they studied the molecular genetics of autophagy in the model organism C. elegans, conducting and analyzing lifespan studies in worms with different genetic backgrounds. Brenda also gained research experience as an Undergraduate Summer Student Researcher at Albert Einstein College of Medicine in June 2012, where they conducted genetic crosses and contributed to the discovery of an unknown gene's role in neuronal development.

Overall, Brenda Gonzalez has a strong background in scientific research, with expertise in genetics, aging, and neurobiology.

Brenda Gonzalez's education history includes various degrees and fields of study. Brenda began their academic journey at Nassau Community College from 2006 to 2008, where they earned an Associate of Arts and Sciences (AAS) degree in Liberal Arts and Sciences/Liberal Studies. Brenda then attended Queens College from 2009 to 2013, where they obtained a Bachelor's degree, specifically a Bachelor of Arts (B.A.), in Biology and Genetics. Afterward, Brenda pursued higher education at Albert Einstein College of Medicine, where they simultaneously completed a Master of Science (M.S.) in Neuroscience from 2013 to 2015 as well as a Doctor of Philosophy (PhD) in Genetics from 2013 to 2019.